How long does brca genetic testing take to work for ovarian cancer?

A BRCA1 or BRCA2 change can be inherited and may influence ovarian cancer risk, family counselling, and choices about treatment or risk reduction. Testing may use blood or saliva, and some cancer pathways also examine tumour tissue; these are not interchangeable because a change found in a tumour may or may not be inherited. Results can be positive, negative, or uncertain. The oncology and genetics teams interpret them alongside the cancer diagnosis, family history, and other test findings.

Ask whether your sample is being tested for a known family change or through a broader panel, and confirm when the result discussion will occur. Continue the treatment and appointment plan already made by your oncology team; do not delay care while waiting unless they specifically advise it. Write down relatives with ovarian, breast, prostate, or pancreatic cancer if known, because this can help the genetics consultation.

Call your oncology team if you develop new or worsening pain, vomiting, difficulty eating or drinking, abdominal swelling, breathlessness, or fever. These symptoms need clinical assessment and should not be attributed to a pending BRCA result. Contact the genetics service if a sample fails, your contact details change, or you do not understand how urgent findings will be communicated.

Ask how BRCA results could affect treatment choices, whether tumour and inherited testing are both needed, when results will be reviewed, and what the findings could mean for close relatives.